Medfinder
Back to blog

Updated: April 10, 2026

The Complete Dotti Shortage Guide for Patients [2026]

Author

Peter Daggett

Peter Daggett

Woman relieved after finding Dotti estradiol patch using a pharmacy search tool

Dotti estradiol patches are in active shortage across the U.S. in 2026. This guide explains what's causing it, which strengths are hardest to find, and exactly what to do.

If your pharmacist just told you Dotti is backordered — or if you've been calling around town with no luck — you're not alone. In 2026, Dotti (estradiol transdermal patch, made by Amneal Pharmaceuticals) is genuinely hard to find at many pharmacies across the United States. This is not a rumor or a regional fluke. It is an active, documented shortage affecting patients nationwide.

This guide covers everything you need to know: what is causing the shortage, which strengths are hardest to find, what you can do right now to get your prescription filled, and what alternatives your doctor can prescribe if Dotti remains unavailable.

Is Dotti Still in Shortage in 2026?

Yes. As of early 2026, Dotti and other estradiol transdermal patches remain in active shortage across much of the United States. The shortage is not limited to Dotti — it affects multiple estradiol patch brands and generics — but Dotti is among the hardest-hit products. The FDA is aware of the situation and has stated it is monitoring estradiol patch supply, but no official resolution date has been announced.

Reports from pharmacies, patients, and wholesalers confirm that supply is significantly below demand. For the latest status updates, see our Dotti shortage update for 2026.

What Is Causing the Dotti Shortage?

The Dotti shortage is the result of several factors hitting at the same time. Here is what happened:

The FDA Removed the HRT Black Box Warning in November 2025

In November 2025, the FDA took a historic step and removed the longstanding black box warning from bioidentical estradiol patches, gels, and creams. That warning had been in place for over 20 years, and it had overstated the risks of hormone replacement therapy (HRT) — discouraging millions of women and their doctors from using it even when the benefits clearly outweighed the risks.

Once the warning was removed, demand for HRT surged almost overnight. Women who had been managing menopause symptoms without treatment began asking their doctors for prescriptions. The result was a massive spike in estradiol patch prescriptions that manufacturers were simply not prepared to handle.

Demand Had Already Been Rising for Years Before the Shortage

The FDA's November 2025 announcement was the tipping point — but the trend had been building for years. Starting around 2020, telehealth menopause companies like Midi Health, Alloy, and Evernow made it easier than ever for women to get prescribed HRT without fighting for an in-person appointment. Social media also played a role, with more women openly sharing their positive experiences with hormone therapy. By the time the black box warning came down, prescription volumes were already climbing steeply.

Manufacturing Estradiol Patches Is Complicated

Estradiol transdermal patches are not simple pills. They require specialized manufacturing facilities and tightly controlled processes. Only a small number of companies produce them in the United States. Amneal Pharmaceuticals — which makes Dotti — and other patch manufacturers cannot simply double their output overnight. Scaling up production typically takes six to eighteen months, which means even if manufacturers are working at full speed right now, supply relief may be months away.

Distribution Is Uneven Across Pharmacies

Even when patches are manufactured and shipped, they do not always reach the pharmacies that need them most. Large chain pharmacies often receive priority allocations from wholesalers — but because they serve more patients, their stock depletes faster. Independent pharmacies may get smaller shipments but sometimes have stock when the major chains are empty. Some regions of the country are hit harder than others, creating uneven availability.

Which Dotti Strengths Are Hardest to Find?

Not all Dotti strengths are equally scarce. Based on reports from pharmacies and patients in early 2026, the mid-range strengths are the hardest to locate:

  • 0.05 mg/day — Most commonly prescribed; most severely affected by the shortage
  • 0.075 mg/day — Also particularly scarce in many areas
  • 0.025 mg/day, 0.0375 mg/day, and 0.1 mg/day — Still affected, but may be slightly easier to find in some regions

If your prescribed strength is unavailable, ask your doctor whether you can temporarily use a different strength combined with a dose adjustment, or switch to a therapeutic equivalent. Do not adjust your dose on your own.

How Long Will the Dotti Shortage Last?

There is no confirmed end date. The FDA is monitoring the situation, and manufacturers like Amneal are working to increase production. However, industry experts suggest the shortage could extend through much of 2026. Because scaling up patch manufacturing takes six to eighteen months, patients should plan for continued difficulty finding Dotti for the foreseeable future — and prepare with the strategies below.

What Should You Do Right Now If You Can't Find Dotti?

Here are the most effective strategies for getting your prescription filled during the shortage:

  1. Use Medfinder to search real-time inventory. Instead of calling pharmacy after pharmacy, Medfinder checks availability across pharmacies in your area all in one place. It is updated regularly, so the information reflects actual current stock.
  2. Try independent pharmacies. Large chains like CVS, Walgreens, and Rite Aid often run out first because they serve the most patients. Independent pharmacies have different supply channels and may have Dotti or generic estradiol patches in stock when the big chains don't.
  3. Check mail-order pharmacies. Amazon Pharmacy, Cost Plus Drugs, and specialty mail-order pharmacies sometimes carry stock when local pharmacies are empty, because they order in larger volumes directly from distributors. This is especially worth trying if your insurance covers mail-order.
  4. Refill early — 7 to 10 days before your last patch. Don't wait until you're out. During a shortage, it can take days to locate a pharmacy with stock. Starting your search early gives you a buffer.
  5. Time your calls strategically. Pharmacies typically receive wholesaler shipments early in the week — Monday through Wednesday. Calling right after a delivery arrives gives you the best chance. Also call in the morning when staff have more time to help.
  6. Ask about upcoming shipments. If a pharmacy is out, ask when they expect their next delivery. Many pharmacies will let you reserve your prescription so it is set aside when the shipment arrives.
  7. Ask your chain pharmacist to check other locations. If you use a chain pharmacy, the pharmacist can check inventory at nearby branches and transfer your prescription to a location that has stock.
  8. Sign up for stock alerts. Medfinder can notify you when Dotti becomes available near you, so you are not starting from scratch every time you need a refill.

What Are the Best Alternatives to Dotti If It's Unavailable?

Dotti contains estradiol — the same active ingredient found in several other products. Switching is usually medically straightforward, though your doctor should supervise the transition. Here are the main options (see our full Dotti alternatives guide for a detailed comparison):

  • Generic estradiol transdermal patches: Multiple manufacturers produce generic versions of the twice-weekly estradiol patch. Ask your pharmacist specifically for a generic — it may be in stock when Dotti is not.
  • Climara (once-weekly patch): A once-weekly estradiol patch from Bayer with somewhat better availability in some areas. Fewer patch changes per month and direct dose equivalence with Dotti.
  • EstroGel or Divigel (topical estradiol gel): These topical gels deliver estradiol without a patch and are generally less affected by the current shortage. EstroGel and Divigel are among the most available transdermal estradiol options right now.
  • Oral estradiol tablets: Estradiol tablets are rarely in shortage and cost as little as $4 to $15 per month. Note that oral estrogen carries a slightly higher clotting risk than transdermal estrogen because it passes through the liver. Your doctor will weigh this against your individual risk profile.

If you are asking your doctor to prescribe a flexible alternative, suggest language like: "Estradiol transdermal 0.05 mg/day, twice weekly — Dotti, generic, or therapeutic equivalent." Avoiding the "Dispense As Written" restriction gives the pharmacist flexibility to fill with whatever is in stock.

Is It Safe to Stop Dotti Suddenly If You Can't Find It?

Do not stop hormone therapy abruptly without talking to your doctor first. Stopping estradiol suddenly can cause a return of menopause symptoms — including hot flashes, night sweats, sleep disruption, and vaginal dryness — sometimes more intensely than before you started treatment. If you are completely out of patches and cannot find a refill, contact your doctor right away. They can prescribe a temporary bridge — such as oral estradiol or estradiol cream — to keep your hormone levels stable until you can get patches again.

How Much Does Dotti Cost During the Shortage?

The shortage has not significantly changed Dotti's pricing, but limited availability means you may not always be able to shop around for the best price. Here is what to expect:

  • Retail cash price: $105 to $191 for a one-month supply (8 patches) without insurance
  • With a GoodRx coupon: As low as $25.83 for a one-month supply
  • With insurance: $10 to $30 copay for most commercial plans and Medicare Part D (coverage has not changed due to the shortage)

Amneal Pharmaceuticals also offers a Patient Assistance Program for eligible patients who cannot afford Dotti. For the full breakdown of all savings options, see our guide to saving money on Dotti in 2026.

Should You Report the Dotti Shortage to the FDA?

Yes. Patient reports help the FDA understand the scope of a shortage and prioritize its response. You can report a drug shortage directly to the FDA by emailing drugshortages@fda.hhs.gov. Include the drug name, strength, your location, and what you were told by the pharmacy. The more patients who report, the more urgently the FDA can act.

The Bottom Line

The Dotti shortage is real, frustrating, and not your fault. A combination of historic demand growth, limited manufacturing capacity, and uneven distribution has created a situation where a medication millions of women depend on is genuinely hard to find. The good news: with the right tools and strategies, most patients can still get their prescriptions filled — it just takes more effort than it used to. Start your search with Medfinder, talk to your doctor about alternatives, and don't wait until your last patch to start looking.

Frequently Asked Questions

Yes. As of early 2026, Dotti (estradiol transdermal patch) is experiencing an active nationwide shortage in the United States. The FDA is monitoring the situation, but no official resolution date has been announced. Supply is significantly below demand at many pharmacies across the country.

The shortage is primarily driven by a massive surge in demand after the FDA removed the black box warning from transdermal HRT products in November 2025. This caused a rapid increase in new prescriptions that manufacturers were not prepared to meet. Estradiol patches also require specialized manufacturing facilities, and scaling production takes 6 to 18 months.

The best alternatives are generic estradiol transdermal patches, Climara (a once-weekly patch), EstroGel or Divigel (topical estradiol gels), or oral estradiol tablets. Talk to your doctor before switching — they can choose the best option based on your health history and adjust your dose if needed.

There is no confirmed end date. Industry experts suggest the shortage could extend through much of 2026 as manufacturers work to scale production to meet the sharply increased demand. Because patch manufacturing requires specialized facilities, scaling up takes 6 to 18 months.

Do not stop hormone therapy without talking to your doctor first. Stopping estradiol abruptly can cause a sudden return of menopause symptoms. If you run out and cannot find a refill, contact your doctor immediately. They can prescribe a temporary alternative — like oral estradiol or estradiol gel — to keep you covered while you search for patches.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for dotti also looked for:

29,490 have already found their meds with Medfinder.

Start your search today.

29K+
5-star ratingTrusted by 29,490 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?